Skip to content

Envista Holdings Corporation NVST Specialty Products & Technologies — Acquisition

Other segment segments

Equipment & Consumables
$0

Similar metrics at other companies

APi Group logo
APGSpecialty Services — Acquisitions
$0
General Dynamics logo
GDTechnologies — Acquisitions
-$4M-131%
Element Solutions logo
ESISpecialties — Acquisitions
$163.6M
Amneal Pharmaceuticals, Inc. logo
AMRXSpecialty — Acquisition costs
$0
Thermo Fisher Scientific logo
TMOSpecialty Diagnostics — Acquisitions
$0
Perimeter Solutions logo
PRMSpecialty Products — Purchases of property and equipment
$2.41M+55.5%

Other financials

Income statement

See full
Revenue$705.5M+14.4%
Gross profit$390.1M+16.1%
Operating income$62.5M+60.3%
Net income$38.7M+115%
EPS (diluted)$0.23+130%

Balance sheet

See full
Cash & equivalents$1.1B+0.5%
Total debt$1.6B+1.8%
Total equity$3.1B+1.4%
Total assets$5.6B+2.0%

Cash flow

See full
Operating cash flow-$3.3M-1,200%
CapEx$12.5M+112%
Free cash flow-$15.8M-182%

Valuation

See full
Market cap$4.11B+39.9%

Profitability

See full
Gross margin54.9%+0.9pp
Operating margin8.5%+4.6pp
Net margin2.4%+1.2pp
FCF margin7.8%-2.9pp

Returns & leverage

See full
Return on equity2.2%+1.1pp
Debt / equity0.5×0.0×
Current ratio2.4×+0.3×

Where this comes from

Reported directly by Envista Holdings Corporation in its filing.

Tagged under the XBRL concept us-gaap:GoodwillAcquiredDuringPeriod.

The official record: Envista Holdings Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envista Holdings Corporation's specialty products & technologies — acquisition.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envista Holdings Corporation's specialty products & technologies — acquisition?
Envista Holdings Corporation (NVST) reported specialty products & technologies — acquisition of $20.2M in Q1 2026.
What does specialty products & technologies — acquisition mean?
Reflects the capital deployed for the purchase of new businesses or assets specifically integrated into the Specialty Products and Technologies segment. This metric captures the company's inorganic growth strategy and its commitment to expanding its dental implant and prosthetics portfolio. It is a key indicator of the firm's appetite for market consolidation and technology acquisition.